BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 4383923)

  • 1. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.
    Dias Da Silva W; Lepow IH
    J Exp Med; 1967 May; 125(5):921-46. PubMed ID: 4960742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plasmin-split fragment of C'3 as a new chemotactic factor.
    Ward PA
    J Exp Med; 1967 Aug; 126(2):189-206. PubMed ID: 4226271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modification of complement factors and their inhibitors during meningococcal sepsis (author's transl)].
    Blanco A; Solís P; Alvarez Guisasola FJ; Valbuena C; Gómez C; Prieto P; Ruíz C
    An Esp Pediatr; 1980 Aug; 13(8):679-88. PubMed ID: 7436149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The third component of the guinea pig complement system. II. Kinetic study of the reaction of EAC'4,2a with guinea pig C'3. Enzymatic nature of C'3 comsumption, multiphasic character of fixation, and hemolytic titration of C'3.
    Shin HS; Mayer MM
    Biochemistry; 1968 Aug; 7(8):2997-3002. PubMed ID: 5666766
    [No Abstract]   [Full Text] [Related]  

  • 7. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    NILSSON UR; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):277-98. PubMed ID: 14316946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.
    Müllerèberhard HJ; Dalmasso AP; Calcott MA
    J Exp Med; 1966 Jan; 123(1):33-54. PubMed ID: 4159289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylatoxin release from the third component of human complement by hydroxylamine.
    Budzko DB; Müller-Eberhard H
    Science; 1969 Aug; 165(3892):506-7. PubMed ID: 5815704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Irregular behavior of complement in coeliac disease (author's transl)].
    Blanco A; Alonso M; Solís P; Calvo C; Catoira A; Sánchez Villares E
    An Esp Pediatr; 1981 Nov; 15(5):449-54. PubMed ID: 7332146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylatoxin in its relation to the complement system.
    Jensen J
    Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    Bokisch VA; Müller-Eberhard HJ; Cochrane CG
    J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.
    Gewurz H; Shin HS; Mergenhagen SE
    J Exp Med; 1968 Nov; 128(5):1049-57. PubMed ID: 4176223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RELEASE OF HISTAMINE FROM RABBIT BLOOD CELLS BY AN ANAPHYLATOXIN-LIKE SUBSTANCE FORMED IN NORMAL AND C'3 DEFECT RABBIT PLASMA.
    GIERTZ H; REUTTER W; SCHMUTZLER W
    Nature; 1964 Jun; 202():1346. PubMed ID: 14210981
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    Müller-Eberhard HJ; Polley MJ; Calcott MA
    J Exp Med; 1967 Feb; 125(2):359-80. PubMed ID: 6019133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited deficiency of the third component of human complement (C'3).
    Alper CA; Propp RP; Klemperer MR; Rosen FS
    J Clin Invest; 1969 Mar; 48(3):553-7. PubMed ID: 5773091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin.
    Snyderman R; Shin HS; Phillips JK; Gewurz H; Mergenhagen SE
    J Immunol; 1969 Sep; 103(3):413-22. PubMed ID: 5805427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.